Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Fidelity MSCI Health Care Index ETF (FHLC) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.08% for FHLC. FTXH is up 5.06% year-to-date (YTD) with +$7M in YTD flows. FHLC performs worse with -0.8% YTD performance, and +$111M in YTD flows. Run a side-by-side ETF comparison of FTXH and FHLC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH FHLC | -0.60%-1.23% | +7.47%+2.15% | +5.06%-0.80% | +22.29%+8.16% | +43.33%+29.48% | +43.47%+37.11% |
| Flows | FTXH FHLC | +$5M+$34M | +$9M+$130M | +$7M+$111M | +$10M-$10M | -$13M-$619M | +$4M-$233M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH FHLC | +15.29%+13.36% | +20.64%+17.33% | +15.87%+13.69% | +15.67%+14.80% |
| Max drawdown | FTXH FHLC | -4.33%-5.00% | -17.49%-11.86% | -19.32%-16.88% | -19.32%-17.78% |
| Max drawdown duration | FTXH FHLC | 9d61d | 203d190d | 393d435d | 393d762d |
FTXH | FHLC | |
Last sale 3/11/2026 at 1:30 PM | $34.46 | $73.01 |
| Previous close 03/10/2026 | $34.57 | $73.17 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
FTXH | FHLC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
FTXH | FHLC | |
|---|---|---|
| Last price | $34.46 | $73.01 |
| 1D performance | -0.33% | -0.22% |
| AuM | $29.41 M | $2.93 B |
| E/R | 0.6% | 0.08% |
FTXH | FHLC | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | Fidelity |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | MSCI USA IMI Health Care Index |
| N° of holdings | 49 | 277 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | October 21, 2013 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
